论文信息 - Radium-223 chloride (Ra-223) impact on skeletal-related events (SREs) and ECOG performance status (PS) in patients with castration-resistant prostate cancer (CRPC) with bone metastases: Interim results of a phase III trial (ALSYMPCA). - 字舞流文

Radium-223 chloride (Ra-223) impact on skeletal-related events (SREs) and ECOG performance status (PS) in patients with castration-resistant prostate cancer (CRPC) with bone metastases: Interim results of a phase III trial (ALSYMPCA).

S. Fosså | C. Parker | P. Hoskin | J. Logue | S. Nilsson | D. Bottomley | N. Vogelzang | M. Shan | J. O’Sullivan | R. Coleman | A. Widmark | D. Heinrich | A. Chodacki | P. Wiechno | M. Seke | D. Johannessen | C. G. O'Bryan-Tear | J. Garcia-Vargas | A. Sartor